NCT03658304
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
417 public trials
125 recruiting studies
Carcinoma, Transitional Cell trial results
NCT03070990
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Cancer, +3 more
- Locations
-
- Site JP00003 Tsukuba, Ibaraki, Japan
- Site JP00005 Sendai, Miyagi, Japan
- Site JP00008 Suita, Osaka, Japan
- Site JP00004 Chuo-ku, Tokyo, Japan
NCT05136898
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Urology Centers of Alabama (UCA) Homewood, Alabama, United States
- Indiana University School of Medicine Indianapolis, Indiana, United States
- Medication Management Greensboro, North Carolina, United States
- Urology Associates, P.C. Nashville, Tennessee, United States
NCT03219333
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
- Locations
-
- Alaska Urological Institute Anchorage, Alaska, United States
- Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
NCT02443324
- Conditions
- Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
- Florida Cancer Specialists Fort Myers, Florida, United States
- Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
- Tennessee Oncology PLLC Chattanooga, Tennessee, United States
NCT03513952
- Conditions
- Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
- Locations
-
- Kaiser Permanente-Riverside Riverside, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Straub Clinic and Hospital Honolulu, Hawaii, United States
- University of Hawaii Cancer Center Honolulu, Hawaii, United States
NCT03752398
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
- Locations
-
- UC San Diego Moores Cancer Center San Diego, California, United States
- University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
NCT03557918
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Georgetown University Washington D.C., District of Columbia, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- University of Kansas Medical Center Research Institute, Inc. Westwood, Kansas, United States
- Dana Farber- Partners Cancer Care, Inc Boston, Massachusetts, United States
NCT02451423
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +2 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT05046665
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Fiona Stanley Hospital Murdoch, Western Australia, Australia